Jump to content

Portal:Viruses

From Wikipedia, the free encyclopedia
(Redirected from Portal:Virology)

The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Hand washing with soap is a protective measure against gastroenteritis
Hand washing with soap is a protective measure against gastroenteritis

Gastroenteritis is an inflammation of the gastrointestinal tract involving both the stomach and small intestine, which results in diarrhoea and vomiting, and sometimes abdominal pain. It is usually caused by a virus: most commonly rotavirus and norovirus, but also adenovirus and astrovirus. Other major infectious causes include Campylobacter, Escherichia coli, Vibrio cholerae and some other bacteria, as well as protozoa. Viruses, particularly rotavirus, cause about 70% of gastroenteritis episodes in children, while norovirus is the leading cause of gastroenteritis among adults in America, causing over 90% of outbreaks.

Transmission can be from consumption of improperly prepared foods or contaminated water, or by close contact with infectious individuals. Good sanitation practices and a convenient supply of uncontaminated water are important for reducing infection. Personal measures such as hand washing with soap can decrease incidence by as much as 30%. An estimated 2 billion cases of gastroenteritis occurred globally in 2015, mainly among children and people in developing countries, resulting in 1.3 million deaths. Gastroenteritis is usually an acute and self-limiting disease that does not require medication; the main treatment is rehydration using oral rehydration therapy. A rotavirus vaccine is available.

Selected image

Culex mosquito larvae

Culex species mosquitoes transmit West Nile virus. Elimination of the stagnant water pools where the mosquitoes breed, together with other mosquito control measures, is key to preventing disease.

Credit: James Gathany (28 February 2006)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Diagram showing adaptive immunity and memory
Diagram showing adaptive immunity and memory

The immune system is a system of structures and processes within an organism that protects against disease. It must detect a wide variety of pathogens – from viruses to parasitic worms – distinguish them from the organism's own healthy tissue, and neutralise them. Simple unicellular organisms such as bacteria have enzymes that protect against bacteriophage infections. Other basic immune mechanisms, including phagocytosis, antimicrobial peptides called defensins, and the complement system, evolved in ancient eukaryotes and are found in plants and invertebrates.

Humans and most other vertebrates have more sophisticated defence mechanisms, including the ability to adapt over time to recognise specific pathogens more efficiently. Adaptive immunity creates immunological memory after an initial response to a specific pathogen, leading to an enhanced response to subsequent encounters with that same pathogen. This process of acquired immunity is the basis of vaccination. Viruses and other pathogens can rapidly evolve to evade immune detection, and some viruses, notably HIV, cause the immune system to function less effectively.

Selected outbreak

Passengers in Mexico City wearing face masks in an attempt to prevent infection
Passengers in Mexico City wearing face masks in an attempt to prevent infection

The 2009 flu pandemic was an influenza pandemic first recognised in Mexico City in March 2009 and declared over in August 2010. It involved a novel strain of H1N1 influenza virus with genes from five different viruses, which resulted when a previous triple reassortment of avian, swine and human influenza viruses further combined with a Eurasian swine influenza virus, leading to the term "swine flu" being used for the pandemic. It was the second pandemic to involve an H1N1 strain, the first being the 1918 "Spanish flu" pandemic.

The global infection rate was estimated as 11–21%. This pandemic strain was less lethal than previous ones, killing about 0.01–0.03% of those infected, compared with 2–3% for Spanish flu. Most experts agree that at least 284,500 people died, mainly in Africa and Southeast Asia – comparable with the normal seasonal influenza fatalities of 290,000–650,000 – leading to claims that the World Health Organization had exaggerated the danger.

Selected quotation

Recommended articles

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

Structure of adeno-associated virus serotype 2

Adeno-associated viruses (AAVs) are two small DNA viruses in the Dependoparvovirus genus of the Parvoviridae family. They cannot complete their lytic replication cycle without a helper virus, which include adenoviruses, herpesviruses and vaccinia. In the absence of the helper, AAVs can integrate into the host genome at a specific site on human chromosome 19, or persist as an episome. The 20 nm icosahedral capsid lacks an envelope, and contains a single-stranded DNA genome of around 4.7 kb. AAVs infect humans and some other primates without causing disease. They generate only a mild immune response, including neutralising antibodies. The best-studied of the 11 serotypes, AAV-2, infects nerve cells, liver cells, skeletal muscle and vascular smooth muscle, using heparan sulphate proteoglycan as its primary receptor.

Its low pathogenicity makes AAV an attractive basis for viral vectors for gene therapy. Alipogene tiparvovec to treat lipoprotein lipase deficiency was the first gene therapy to be licensed, but was later withdrawn. Promising results have been obtained in early clinical trials with AAV-based gene therapy in haemophilia, congestive heart failure, spinal muscular atrophy, Parkinson's disease and the rare eye disease Leber congenital amaurosis.

Did you know?

C5 strain of plum
C5 strain of plum

Selected biography

Peter Piot in 2006

Peter Piot (born 17 February 1949) is a Belgian virologist and public health specialist, known for his work on Ebola virus and HIV.

During the first outbreak of Ebola in Yambuku, Zaire in 1976, Piot was one of a team that discovered the filovirus in a blood sample. He and his colleagues travelled to Zaire to help to control the outbreak, and showed that the virus is transmitted via blood and during preparation of bodies for burial. He advised WHO during the West African Ebola epidemic of 2014–16.

In the 1980s, Piot participated in collaborative projects in Burundi, Côte d'Ivoire, Kenya, Tanzania and Zaire, including Project SIDA in Kinshasa, the first international project on AIDS in Africa, which provided the foundations for understanding HIV infection in that continent. He was the founding director of UNAIDS, and has served as president of the International AIDS Society and assistant director of the WHO Global HIV/AIDS Programme. As of 2020, he directs the London School of Hygiene & Tropical Medicine.

In this month

Red ribbon signifying solidarity with people living with HIV/AIDS

5 June 1981: First report of HIV/AIDS (symbol pictured) appeared in medical literature

6 June 1997: Gene silencing in plants shown to be a viral defence mechanism

7–13 June 1962: Donald Caspar and Aaron Klug proposed the quasi-equivalence principle of virus structure

7–13 June 1962: André Lwoff proposed a viral classification scheme based on nature of genome, type of symmetry and presence of envelope

7–13 June 1962: George Hirst proposed that the influenza virus genome is segmented

9 June 1981: The American Society for Virology was founded

13 June 2012: First case of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Saudi Arabia

18 June 1981: A vaccine against foot-and-mouth disease was the first genetically engineered vaccine

21 June 1996: Nevirapine approved, first NNRTI for HIV/AIDS

26 June 1993: Clinical trial of hepatitis B virus drug fialuridine terminated; the drug caused several fatalities due to lactic acidosis

28 June 2011: FAO declared rinderpest eradicated

30 June 1985: Ryan White was denied re-admittance to his school after an AIDS diagnosis, in a case that changed public perceptions of the disease

Selected intervention

Ball-and-stick model of nevirapine

Nevirapine (also Viramune) is an antiretroviral drug used in the treatment of HIV/AIDS caused by HIV-1. It was the first non-nucleoside reverse transcriptase inhibitor to be licensed, which occurred in 1996. Like nucleoside inhibitors, nevirapine inhibits HIV's reverse transcriptase enzyme, which copies the viral RNA into DNA and is essential for its replication. Unlike nucleoside inhibitors, it binds not in the enzyme's active site but in a nearby hydrophobic pocket, causing a conformational change in the enzyme that prevents it from functioning. Mutations in the pocket generate resistance to nevirapine, which develops rapidly unless viral replication is completely suppressed. The drug is therefore only used together with other anti-HIV drugs in combination therapy. The HIV-2 reverse transcriptase has a different pocket structure, rendering it inherently resistant to nevirapine and other first-generation NNRTIs. A single dose of nevirapine is a cost-effective way to reduce mother-to-child transmission of HIV, and has been recommended by the World Health Organization for use in resource-poor settings. Other protocols are recommended in the United States. Rash is the most common adverse event associated with the drug.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: